Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Toulon, Var, 83056, France
NCT Number: NCT06853353
The management of chronic heart failure, following current guidelines, requires the implementation and adjustment of therapies to limit mortality and morbidity associated with disease progression. However, this period of treatment titration remains challenging due to the need for multiple, closely spaced consultations. The difficulty in maintaining this consultation frequency, coupled with the current decline in medical demographics, largely explains the lack of treatment titration or even initiation and the existing therapeutic inertia. Concurrently, medical telemonitoring is emerging as an essential tool in heart failure management, offering significant benefits for both patients and healthcare professionals.
In this context, new forms of nursing practices have emerged, such as advanced practice nursing, aimed at improving the care of patients with chronic diseases. However, only limited data are currently available regarding the functioning and impact of these consultations in France.
The "Evaluation and Support Pathway for Heart Failure Patients (FIL-EAS ic)" has systematically integrated this new model of consultations provided by heart failure nurse specialists. Given their significant and growing role within the pathway, it appears necessary to thoroughly evaluate these consultations to propose improvements and maximize their effectiveness.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Toulon, Var, 83056, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Heart Failure Specialist Nurses consultations
Time frame: 1-year period
Medical telemonitoring, treatment titration, advanced practice nurse follow-up
Time frame: 1-year period
Patient's clinical characteristics will be analyzed : number and type of medical histories
Time frame: 1-year period
Type and dose of treatment initiated for heart failure will be analyzed.
Time frame: 1-year period
The number of consultations will be analyzed by type of activity (medical telemonitoring, treatment titration, advanced practice nurse follow-up).
Time frame: 1-year period
The number of hospitalizations and re-hospitalizations during the 12 months of follow-up will be analyzed.
Time frame: 1-year period
The type of referral will be analyzed : in-hospital (cardiology or non-cardiology) or out-of-hospital (cardiologist, general practitioner, private nurse or Advanced Practice Registered Nurse)
Time frame: 1-year period
The reason for the discontinuation of titration consultations will be analyzed.
Time frame: 1-year period
Echocardiography data during therapy titration will be analyzed.
Time frame: 1-year period
Modification of recommended treatment doses in heart failure will be analyzed in the overall cohort and according to the level of LVEF at initial management.
Time frame: 1-year period
The rate of detection of iron deficiency will be analyzed according to whether or not Ferinject supplementation is used.
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Other
Acronym: ISPIC FILEAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07697365
Cardiovascular Diseases, Chronic Heart Failure
Athens, Attica, Greece
View Trial DetailsNCT07599345
Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction
Boston, Massachusetts, United States
View Trial DetailsNCT07599293
Chronic Heart Failure, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT06299826
Chronic Heart Failure
Alexander City, Alabama, United States
View Trial Details